Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011, Article ID 235653, 7 pages
http://dx.doi.org/10.4061/2011/235653
Research Article

Possible Association of High Urinary Magnesium and Taurine to Creatinine Ratios with Metabolic Syndrome Risk Reduction in Australian Aboriginals

1Institute for World Health Development, Mukogawa Women’s University, Nishinomiya, Hyogo 663 8143, Japan
2Department of Sustainability and Environment, East Melbourne, VIC 3002, Australia
3Kirrae Health Service, Purim, VIC 3278, Australia

Received 15 September 2010; Accepted 31 January 2011

Academic Editor: Christina Chrysohoou

Copyright © 2011 Atsumi Hamada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. M. Lakka, D. E. Laaksonen, T. A. Lakka et al., “The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men,” Journal of the American Medical Association, vol. 288, no. 21, pp. 2709–2716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepistö, M. Laakso, and J. Kuusisto, “The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns,” European Heart Journal, vol. 28, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. Valery, A. Moloney, A. Cotterill, M. Harris, A. K. Sinha, and A. C. Green, “Prevalence of obesity and metabolic syndrome in Indigenous Australian youths,” Obesity Reviews, vol. 10, no. 3, pp. 255–261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. L. Thompson, P. J. Bradshaw, M. Veroni, and E. T. Wilkes, “Cardiovascular risk among urban Aboriginal people,” Medical Journal of Australia, vol. 179, no. 3, pp. 143–146, 2003. View at Google Scholar · View at Scopus
  5. The health of Aboriginal Victorians, Victorian Aboriginal Community Controlled Health Organisation, 2009, http://www.vaccho.org.au/rw_documents/Aboriginal_PH_description_1%20Robert%20Hall%20010409.pdf.
  6. M. Gracey, “Historical, cultural, political, and social influences on dietary patterns and nutrition in Australian aboriginal children,” American Journal of Clinical Nutrition, vol. 72, no. 5, supplement 1, pp. 1361S–1367S, 2000. View at Google Scholar · View at Scopus
  7. L. M. Klevay and D. B. Milne, “Low dietary magnesium increases supraventricular ectopy,” American Journal of Clinical Nutrition, vol. 75, no. 3, pp. 550–554, 2002. View at Google Scholar · View at Scopus
  8. N. L. S. Tang, Y. K. Cran, E. Hui, and J. Woo, “Application of urine magnesium/creatinine ratio as an indicator for insufficient magnesium intake,” Clinical Biochemistry, vol. 33, no. 8, pp. 675–678, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Beydoun, T. L. Gary, B. H. Caballero, R. S. Lawrence, L. J. Cheskin, and Y. Wang, “Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome,” American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1914–1925, 2008. View at Google Scholar · View at Scopus
  10. D. P. Chaudhary, R. Sharma, and D. D. Bansal, “Implications of magnesium deficiency in type 2 diabetes: a review,” Biological Trace Element Research, vol. 134, no. 2, pp. 119–129, 2010. View at Publisher · View at Google Scholar
  11. M. D. L. Lima, T. Cruz, L. E. Rodrigues et al., “Serum and intracellular magnesium deficiency in patients with metabolic syndrome—evidences for its relation to insulin resistance,” Diabetes Research and Clinical Practice, vol. 83, no. 2, pp. 257–262, 2009. View at Publisher · View at Google Scholar
  12. L. J. Dominguez, M. Barbagallo, J. R. Sowers, and L. M. Resnick, “Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 12, pp. 4402–4407, 1998. View at Google Scholar · View at Scopus
  13. M. Barbagallo and L. J. Dominguez, “Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance,” Archives of Biochemistry and Biophysics, vol. 458, no. 1, pp. 40–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. I. C. Wells, “Evidence that the etiology of the syndrome containing type 2 diabetes mellitus results from abnormal magnesium metabolism,” Canadian Journal of Physiology and Pharmacology, vol. 86, no. 1-2, pp. 16–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. W. Balon, J. L. Gu, Y. Tokuyama, A. P. Jasman, and J. L. Nadler, “Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM,” American Journal of Physiology, vol. 269, no. 4, pp. E745–E752, 1995. View at Google Scholar · View at Scopus
  16. D. A. Longstreet, D. L. Heath, K. S. Panaretto, and R. Vink, “Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in indigenous Australians,” Rural and Remote Health, vol. 7, no. 4, p. 843, 2007. View at Google Scholar · View at Scopus
  17. Y. Song, J. E. Manson, J. E. Buring, and S. Liu, “Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women,” Diabetes Care, vol. 27, no. 1, pp. 59–65, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Laidlaw, M. Grosvenor, and J. D. Kopple, “The taurine content ofcommon foodstuffs,” Journal of Parenteral and Enteral Nutrition, vol. 14, no. 2, pp. 183–188, 1990. View at Google Scholar
  19. S. A. Laidlaw, M. Grosvenor, and J. D. Kopple, “Erratum: Taurine content of common foodstuffs,” Journal of Parenteral and Enteral Nutrition, vol. 14, no. 4, p. 380, 1990. View at Google Scholar · View at Scopus
  20. M. Njelekela, K. Ikeda, J. Mtabaji, and Y. Yamori, “Dietary habits, plasma polyunsaturated fatty acids and selected coronary disease risk factors in Tanzania,” East African Medical Journal, vol. 82, no. 11, pp. 572–578, 2005. View at Google Scholar · View at Scopus
  21. M. Laidlaw and B. J. Holub, “Effects of supplementation with fish oil-derived n-3 fatty acids and γ-linolenic acid on circulating plasma lipids and fatty acid profiles in women,” American Journal of Clinical Nutrition, vol. 77, no. 1, pp. 37–42, 2003. View at Google Scholar · View at Scopus
  22. H. Yokogoshi, H. Mochizuki, K. Nanami, Y. Hida, F. Miyachi, and O. Hiroaki, “Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet,” Journal of Nutrition, vol. 129, no. 9, pp. 1705–1712, 1999. View at Google Scholar · View at Scopus
  23. M. Zhang, L. F. Bi, J. H. Fang et al., “Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects,” Amino Acids, vol. 26, no. 3, pp. 267–271, 2004. View at Google Scholar · View at Scopus
  24. N. Tsuboyama-Kasaoka, C. Shozawa, K. Sano et al., “Taurine (2-Aminoethanesulfonic Acid) deficiency creates a vicious circle promoting obesity,” Endocrinology, vol. 147, no. 7, pp. 3276–3284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Hamada, M. Mori, and H. Mori, “Deterioration of traditional dietary custom increases the risk of lifestyle-related diseases in young male Africans,” Journal of Biomedical Science, vol. 17, supplement 1, p. S34, 2010. View at Google Scholar
  26. P. S. Patel, S. J. Sharp, R. N. Luben et al., “Association between type of dietary fish and seafood intake and the risk of incident type 2 diabetes. The European Prospective Investigation of Cancer (EPIC)-Norfolk cohort study,” Diabetes Care, vol. 32, no. 10, pp. 1857–1863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Brand-Miller and S. H. A. Holt, “Australian Aboriginal plant foods: a consideration of their nutritional composition and health implications,” Nutrition Research Reviews, vol. 11, no. 1, pp. 5–23, 1998. View at Google Scholar · View at Scopus
  28. K. O'Dea, J. Cunningham, L. Maple-Brown et al., “Diabetes and cardiovascular risk factors in urban Indigenous adults: results from the DRUID study,” Diabetes Research and Clinical Practice, vol. 80, no. 3, pp. 483–489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Yamori, T. Taguchi, H. Mori, and M. Mori, “Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world,” Journal of Biomedical Science, vol. 17, supplement 1, p. S21, 2010. View at Google Scholar
  30. Y. Yamori, S. Murakami, K. Ikeda, and Y. Nara, “Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine,” Clinical and Experimental Pharmacology & Physiology, vol. 31, pp. S20–S23, 2004. View at Google Scholar · View at Scopus
  31. T. Ohira, J. M. Peacock, H. Iso, L. E. Chambless, W. D. Rosamond, and A. R. Folsom, “Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study,” American Journal of Epidemiology, vol. 169, no. 12, pp. 1437–1444, 2009. View at Publisher · View at Google Scholar
  32. M. Barbagallo, L. J. Dominguez, A. Galioto, A. Pineo, and M. Belvedere, “Oral magnesium supplementation improves vascular function in elderly diabetic patients,” Magnesium Research, vol. 23, no. 3, pp. 131–137, 2010. View at Google Scholar
  33. L.-j. Wang, Y.-h. Yu, L.-g. Zhang et al., “Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas,” European Journal of Pharmacology, vol. 597, no. 1–3, pp. 75–80, 2008. View at Publisher · View at Google Scholar
  34. M. Mori, H. Mori, A. Hamada, and Y. Yamori, “Taurine in morning spot urine for the useful assessment of dietary seafood intake in Japanese children and adolescents,” Journal of Biomedical Science, vol. 17, supplement 1, p. S43, 2010. View at Publisher · View at Google Scholar